GSK Partners with Hengrui Pharma to Advance COPD and Oncology Drug Pipeline
GSK plc announced it has entered into agreements with Hengrui Pharma to…
Pfizer Completes Licensing Agreement with 3SBio
Exclusive license to promising investigational cancer immunotherapy complements and strengthens Pfizer’s innovative…
Cristian Massacesi Appointed Executive Vice President, Chief Medical Officer and Head of Development at Bristol Myers Squibb
Bristol Myers Squibb announced the appointment of Cristian Massacesi, M.D., as Executive…
GSK Completes Acquisition of Efimosfermin
GSK plc announced the completion of its previously announced acquisition of efimosfermin alfa from…
Sanofi Expands Immunology Footprint with $9.1 Billion Blueprint Medicines Acquisition
Sanofi has announced an agreement to acquire Blueprint Medicines Corporation, a US-based…
